On June 2, 2025, the U.S. Food and Drug Administration (FDA) announced the deployment of its own artificial intelligence system, “Elsa.” The large language model-powered system was scheduled for full-scale implementation across the agency by June 30, 2025. Initially piloted for FDA scientific reviewers, Elsa is intended to streamline internal processes and increase operational
The bar is rising for the developers of generative artificial intelligence (AI) platforms and other companies that utilize generative AI in public-facing applications. As AI becomes more integrated into everyday products and services—and as litigation involving these uses evolves—avoiding legal liability and maintaining regulatory compliance will be something of a moving target but one that
This post is the first in our three-part series, Gearing Up for HTLH USA 2025, where our team of attorneys will share insights on intellectual property, equity, and exit strategies and how these issues intersect in the transactional context.
Physicians are driving much of today’s health innovation. From new devices and digital tools to
Key point: Recent legislative efforts in Massachusetts, seeking to add another comprehensive data privacy law to the national patchwork of state laws, and in California enacting a law to regulate AI development, occurred this week when the Massachusetts Senate unanimously sent Senate Bill 2608 to the state House, and California enacted the nation’s second substantive
Key point: The California Legislature is considering a bill that would impose comprehensive requirements on the development, deployment, and use of artificial intelligence (AI) systems, with a focus on transparency, accountability, and risk mitigation.
Key point: During Colorado’s legislative special session, which aimed to address budgetary shortfalls resulting from this year’s federal appropriations act, lawmakers approved a delay in the Colorado AI Act’s effective dates.
In June 2025, the Department of Justice (DOJ) announced its 2025 National Health Care Fraud Takedown, marking the largest coordinated healthcare fraud enforcement action in DOJ history. The sweep included charges against a range of actors including alleged transnational criminal organizations, providers of allegedly fraudulent wound care, alleged prescription opioid traffickers, alleged telemedicine, and
In the closely watched case Mobley v. Workday, the Northern District of California recently granted preliminary certification of a collective action for age discrimination claims against Workday’s AI-based applicant recommendation system. The court’s order allows the plaintiff to notify similarly situated individuals of the lawsuit and give them an opportunity to opt-in to having their
Key point: “Winning the Race: America’s AI Action Plan,” the Trump Administration’s summary approach to federal artificial intelligence (AI) policy, and three new Executive Orders (EO) propose a wide-ranging federal strategy intended to solidify U.S. leadership in AI. For business leaders and public sector stakeholders, the Action Plan and EOs may be a double-edged sword:
Commerce Initiates Section 232 Investigation On Drones and Polysilicon from China
On July 16, 2026, the U.S. Department of Commerce launched new Section 232 investigations on imports of Chinese drones and polysilicon. Drones and polysilicon are both currently subject to additional tariffs of 55% and 80%, respectively. The new investigations aim to assess whether